Clinical trial
Nesiritide and Vo2 Max in Heart Failure Patients
NCT00240084 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nesiritide and Vo2 Max in Heart Failure Patients
- Lead sponsor
- University of Rochester
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- November 30, 2005
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.